%A Meng,Yutong %A Li,Xiaozhi %D 2021 %J Frontiers in Genetics %C %F %G English %K oral squamous cell carcinoma,Sumoylation,post-translational modification,prognosis,biomarkers %Q %R 10.3389/fgene.2021.671392 %W %L %N 1063 %M %P %7 %8 2021-June-29 %9 Original Research %# %! SUMOylation regulators in oral squamous cell carcinoma %* %< %T Expression and Prognosis Analysis of SUMOylation Regulators in Oral Squamous Cell Carcinoma Based on High-Throughput Sequencing %U https://www.frontiersin.org/article/10.3389/fgene.2021.671392 %V 12 %0 JOURNAL ARTICLE %@ 1664-8021 %X IntroductionOral squamous cell carcinoma (OSCC) originates from oral mucosal epithelial cells, accounting for more than 90% of oral cancers. The relationship between the expression and prognostic role of SUMOylation regulators in OSCC is rarely studied.Materials and methodsThe expression and survival data of OSCC were derived from TCGA and GEO databases. Wilcoxon test was used to determine the differential expression of the SUMOylation regulators. A prognostic model based on SUMOylation regulator-related genes was constructed by Cox regression. Gene set enrichment analysis was applied to predict the potential biological functions that the genes might be involved in.ResultsRANBP2 and SENP6 had the highest SNV frequency. Eleven genes including PIAS3, RANBP2, USPL1, SENP6, SENP2, SENP5, SAE1, UBA2, PIAS4, UBE2I, and SENP3 were highly expressed in OSCC. The prognostic model based on nine SUMOylation-regulated genes (TRIM37, UFM1, FUBP1, CCNT1, FXR1, HMG20A, RANBP3, SPATA5, and DDX23) had a strong ability to predict the prognosis of OSCC.ConclusionThis study might provide targets for prognostic evaluation and targeted therapy of patients with OSCC.